Onvatilimab
Product Specifications
CAS Number
1969313-51-6
Target
PD-1/PD-L1|||Others
Related Pathways
Others|||Apoptosis|||Cell Cycle/Checkpoint|||Immunology/Inflammation
Purity
0.9811
Bioactivity
Onvatilimab (JNJ-61610588) is a human IgG1 ?-anti-Vista (T-cell-activated V-domain Ig inhibitor) monoclonal antibody with antitumor activity, potentially used for treating advanced head and neck cancers.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/64416316517253266/T76696
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6196356-01 0.1 mL
KDR (Kinase Insert Domain Receptor (a Type III Receptor Tyrosine Kinase), CD309, FLK1, VEGFR, VEGFR2) (MaxLight 405)
Ask
View Details MBS6196356-02 5x 0.1 mL
KDR (Kinase Insert Domain Receptor (a Type III Receptor Tyrosine Kinase), CD309, FLK1, VEGFR, VEGFR2) (MaxLight 405)
Ask
View Details 
GTR15329645 1 Vial
Lentiviral human SH3D19 shRNA (UAS) - Lentiviral human SH3D19 shRNA (UAS, iRFP) (25)
Ask
View Details